Loading…

5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors

A novel series of 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidines containing substituted phenyl sulfonamide are synthesized and evaluated for their inhibitory activity against CaMKII. Substituents on the phenyl group had significant impact on CaMKII inhibition, in particular, the inhibitory activity of 8...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2010-11, Vol.20 (22), p.6696-6698
Main Authors: Asano, Shigehiro, Komiya, Masafumi, Koike, Nobuyuki, Koga, Erina, Nakatani, Shogo, Isobe, Yoshiaki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c417t-75b0126b751aa95ea1b667c236a87d07e144cc415f29658a3b651d0d8ac6c6393
cites cdi_FETCH-LOGICAL-c417t-75b0126b751aa95ea1b667c236a87d07e144cc415f29658a3b651d0d8ac6c6393
container_end_page 6698
container_issue 22
container_start_page 6696
container_title Bioorganic & medicinal chemistry letters
container_volume 20
creator Asano, Shigehiro
Komiya, Masafumi
Koike, Nobuyuki
Koga, Erina
Nakatani, Shogo
Isobe, Yoshiaki
description A novel series of 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidines containing substituted phenyl sulfonamide are synthesized and evaluated for their inhibitory activity against CaMKII. Substituents on the phenyl group had significant impact on CaMKII inhibition, in particular, the inhibitory activity of 8p was 25-fold higher than that of KN-93, a known CaMKII inhibitor. Michaelis–Menten analysis of a representative compound suggested that the synthesized pyrimidines are calmodulin non-competitive inhibitors. Finally, 8p exhibited more than 100-fold higher selectivity for CaMKII over five types of off-target kinases.
doi_str_mv 10.1016/j.bmcl.2010.09.005
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_867749891</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X10012965</els_id><sourcerecordid>759323660</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-75b0126b751aa95ea1b667c236a87d07e144cc415f29658a3b651d0d8ac6c6393</originalsourceid><addsrcrecordid>eNqFkU9vEzEQxS1ERdPCF-CAfEFcsul4_W8tcUERhYhWXIqEhJDltb3E0Wad2ptI-fZ4lQA3ehrN6DdvRu8h9JrAggARN5tFu7X9ooYyALUA4M_QjDDBKsqAP0czUAKqRrHvl-gq5w0AYcDYC3RZQyO5pM0MbfhczOW8qR78mMz66FLcHVNw8Qeb08r9nJptcGHwGZuMh3jwPba9yRnHDu_i6IcRm8Hhdfi17o84-97bMRw8Xpr7L6sVDsM6tGGMKb9EF53ps391rtfo2-3Hh-Xn6u7rp9Xyw11lGZFjJXkLpBat5MQYxb0hrRDS1lSYRjqQnjBmC8q7WgneGNoKThy4xlhhBVX0Gr076e5SfNz7POptyNb3vRl83GfdCCmZahR5kpRc0XJXQCHrE2lTzDn5Tu-KLyYdNQE9haE3egpDT2FoULqEUZbenOX37da7vyt_3C_A2zNgsjV9l8xgQ_7HUap4LSah9yfOF9sOwSedbfCD9S6k4rZ2Mfzvj98bjKZv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>759323660</pqid></control><display><type>article</type><title>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors</title><source>ScienceDirect Journals</source><creator>Asano, Shigehiro ; Komiya, Masafumi ; Koike, Nobuyuki ; Koga, Erina ; Nakatani, Shogo ; Isobe, Yoshiaki</creator><creatorcontrib>Asano, Shigehiro ; Komiya, Masafumi ; Koike, Nobuyuki ; Koga, Erina ; Nakatani, Shogo ; Isobe, Yoshiaki</creatorcontrib><description>A novel series of 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidines containing substituted phenyl sulfonamide are synthesized and evaluated for their inhibitory activity against CaMKII. Substituents on the phenyl group had significant impact on CaMKII inhibition, in particular, the inhibitory activity of 8p was 25-fold higher than that of KN-93, a known CaMKII inhibitor. Michaelis–Menten analysis of a representative compound suggested that the synthesized pyrimidines are calmodulin non-competitive inhibitors. Finally, 8p exhibited more than 100-fold higher selectivity for CaMKII over five types of off-target kinases.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2010.09.005</identifier><identifier>PMID: 20875738</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines ; Analytical, structural and metabolic biochemistry ; Biological and medical sciences ; Calcium-Calmodulin-Dependent Protein Kinase Type 2 - antagonists &amp; inhibitors ; Calmodulin-dependent protein kinase II ; Enzymes and enzyme inhibitors ; Fundamental and applied biological sciences. Psychology ; Inhibitors ; Medical sciences ; Miscellaneous ; Pharmacology. Drug treatments ; Protein Kinase Inhibitors - pharmacology ; Pyrimidines - pharmacology ; Transferases</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2010-11, Vol.20 (22), p.6696-6698</ispartof><rights>2010 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-75b0126b751aa95ea1b667c236a87d07e144cc415f29658a3b651d0d8ac6c6393</citedby><cites>FETCH-LOGICAL-c417t-75b0126b751aa95ea1b667c236a87d07e144cc415f29658a3b651d0d8ac6c6393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23395265$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20875738$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Asano, Shigehiro</creatorcontrib><creatorcontrib>Komiya, Masafumi</creatorcontrib><creatorcontrib>Koike, Nobuyuki</creatorcontrib><creatorcontrib>Koga, Erina</creatorcontrib><creatorcontrib>Nakatani, Shogo</creatorcontrib><creatorcontrib>Isobe, Yoshiaki</creatorcontrib><title>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A novel series of 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidines containing substituted phenyl sulfonamide are synthesized and evaluated for their inhibitory activity against CaMKII. Substituents on the phenyl group had significant impact on CaMKII inhibition, in particular, the inhibitory activity of 8p was 25-fold higher than that of KN-93, a known CaMKII inhibitor. Michaelis–Menten analysis of a representative compound suggested that the synthesized pyrimidines are calmodulin non-competitive inhibitors. Finally, 8p exhibited more than 100-fold higher selectivity for CaMKII over five types of off-target kinases.</description><subject>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Biological and medical sciences</subject><subject>Calcium-Calmodulin-Dependent Protein Kinase Type 2 - antagonists &amp; inhibitors</subject><subject>Calmodulin-dependent protein kinase II</subject><subject>Enzymes and enzyme inhibitors</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Inhibitors</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Pyrimidines - pharmacology</subject><subject>Transferases</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFkU9vEzEQxS1ERdPCF-CAfEFcsul4_W8tcUERhYhWXIqEhJDltb3E0Wad2ptI-fZ4lQA3ehrN6DdvRu8h9JrAggARN5tFu7X9ooYyALUA4M_QjDDBKsqAP0czUAKqRrHvl-gq5w0AYcDYC3RZQyO5pM0MbfhczOW8qR78mMz66FLcHVNw8Qeb08r9nJptcGHwGZuMh3jwPba9yRnHDu_i6IcRm8Hhdfi17o84-97bMRw8Xpr7L6sVDsM6tGGMKb9EF53ps391rtfo2-3Hh-Xn6u7rp9Xyw11lGZFjJXkLpBat5MQYxb0hrRDS1lSYRjqQnjBmC8q7WgneGNoKThy4xlhhBVX0Gr076e5SfNz7POptyNb3vRl83GfdCCmZahR5kpRc0XJXQCHrE2lTzDn5Tu-KLyYdNQE9haE3egpDT2FoULqEUZbenOX37da7vyt_3C_A2zNgsjV9l8xgQ_7HUap4LSah9yfOF9sOwSedbfCD9S6k4rZ2Mfzvj98bjKZv</recordid><startdate>20101115</startdate><enddate>20101115</enddate><creator>Asano, Shigehiro</creator><creator>Komiya, Masafumi</creator><creator>Koike, Nobuyuki</creator><creator>Koga, Erina</creator><creator>Nakatani, Shogo</creator><creator>Isobe, Yoshiaki</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20101115</creationdate><title>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors</title><author>Asano, Shigehiro ; Komiya, Masafumi ; Koike, Nobuyuki ; Koga, Erina ; Nakatani, Shogo ; Isobe, Yoshiaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-75b0126b751aa95ea1b667c236a87d07e144cc415f29658a3b651d0d8ac6c6393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Biological and medical sciences</topic><topic>Calcium-Calmodulin-Dependent Protein Kinase Type 2 - antagonists &amp; inhibitors</topic><topic>Calmodulin-dependent protein kinase II</topic><topic>Enzymes and enzyme inhibitors</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Inhibitors</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Pyrimidines - pharmacology</topic><topic>Transferases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Asano, Shigehiro</creatorcontrib><creatorcontrib>Komiya, Masafumi</creatorcontrib><creatorcontrib>Koike, Nobuyuki</creatorcontrib><creatorcontrib>Koga, Erina</creatorcontrib><creatorcontrib>Nakatani, Shogo</creatorcontrib><creatorcontrib>Isobe, Yoshiaki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Asano, Shigehiro</au><au>Komiya, Masafumi</au><au>Koike, Nobuyuki</au><au>Koga, Erina</au><au>Nakatani, Shogo</au><au>Isobe, Yoshiaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2010-11-15</date><risdate>2010</risdate><volume>20</volume><issue>22</issue><spage>6696</spage><epage>6698</epage><pages>6696-6698</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>A novel series of 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidines containing substituted phenyl sulfonamide are synthesized and evaluated for their inhibitory activity against CaMKII. Substituents on the phenyl group had significant impact on CaMKII inhibition, in particular, the inhibitory activity of 8p was 25-fold higher than that of KN-93, a known CaMKII inhibitor. Michaelis–Menten analysis of a representative compound suggested that the synthesized pyrimidines are calmodulin non-competitive inhibitors. Finally, 8p exhibited more than 100-fold higher selectivity for CaMKII over five types of off-target kinases.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>20875738</pmid><doi>10.1016/j.bmcl.2010.09.005</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2010-11, Vol.20 (22), p.6696-6698
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_867749891
source ScienceDirect Journals
subjects 5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines
Analytical, structural and metabolic biochemistry
Biological and medical sciences
Calcium-Calmodulin-Dependent Protein Kinase Type 2 - antagonists & inhibitors
Calmodulin-dependent protein kinase II
Enzymes and enzyme inhibitors
Fundamental and applied biological sciences. Psychology
Inhibitors
Medical sciences
Miscellaneous
Pharmacology. Drug treatments
Protein Kinase Inhibitors - pharmacology
Pyrimidines - pharmacology
Transferases
title 5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A58%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=5,6,7,8-Tetrahydropyrido%5B4,3-d%5Dpyrimidines%20as%20novel%20class%20of%20potent%20and%20highly%20selective%20CaMKII%20inhibitors&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Asano,%20Shigehiro&rft.date=2010-11-15&rft.volume=20&rft.issue=22&rft.spage=6696&rft.epage=6698&rft.pages=6696-6698&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2010.09.005&rft_dat=%3Cproquest_cross%3E759323660%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c417t-75b0126b751aa95ea1b667c236a87d07e144cc415f29658a3b651d0d8ac6c6393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=759323660&rft_id=info:pmid/20875738&rfr_iscdi=true